Skip to main content
News Icon

News categories: Honors & Funding

Congratulations to the recipients of the SFB/ Transregio grants:

University of Bonn researchers were successful in the securing SFB/Transregio grants.The SFB/Transregio Aortic Diseases will be working on basic and clinical research on expanding the understanding of fundamental principles in the pathogenesis of aortic diseases. The SFB/Transregio Cellular mechanisms of antibiotic action and production intends to further investigate the biochemical production and action mechanisms of antibiotics.

Related news

Nobel Prize 2025 in Physiology or Medicine

News categories: Honors & Funding

They discovered how the immune system is kept in check

The body’s powerful immune system must be regulated, or it may attack our own organs. Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi are awarded the Nobel Prize in Physiology or Medicine 2025 for their groundbreaking discoveries concerning peripheral immune tolerance that prevents the immune system from harming the body.
View entry
MIB vl Future Panel 021025

News categories: Honors & Funding

Successful MIB Future Panel 2025 in Bonn

the MIB Future Panel 2025, organized by the Medical Imaging Center Bonn (MIB) and the Transfer Team of the Medical Faculty Bonn, once again offered an exciting platform for exchange among science, clinics, start-ups, industry, and investors — with a special focus on medical imaging and artificial intelligence (AI).
View entry
Prof. Dr. Kaan Boztug

News categories: Honors & Funding

Kaan Boztug awarded Novartis Prize

Prof. Dr. Kaan Boztug from the University Hospital Bonn (UKB) receives the Novartis Prize for Therapy-Relevant Immunological Research 2025. The expert in rare diseases of the immune system and blood formation conducted most of the research work that has now been honored in Vienna. His work was supported by an ERC Starting Grant (ImmunoCore, 2012-2018) and an ERC Consolidator Grant (iDysChart, 2019-2025), among others. The science prize, worth 10,000 € is divided into two parts this time and also goes to Prof. Dr. Evelyn Ullrich.
View entry

Back to the news overview